International Diabetes Federation (IDF) Global Survey Reveals 2 in 3 People With Type 2 Diabetes Have Cardiovascular Disease Risk Factors and/or Have Experienced a Cardiovascular Event

PR75462

BAGSVÆRD, Denmark, September 28, 2018, /PRNewswire=KYODO JBN/--

    - Cardiovascular disease (CVD) is the leading cause of disability and death

in people with type 2 diabetes[1]

    - Despite the high incidence, 1 in 4 people with type 2 diabetes have never

discussed, or cannot recall discussing, CVD risk factors with a doctor[2]

    - First-ever global IDF survey investigating CVD awareness among people

with type 2 diabetes received more than 12,000 responses in over 130

countries[2]

    To mark World Heart Day on 29 September, the International Diabetes

Federation (IDF) [http://www.idf.org ] in partnership with Novo Nordisk is

announcing results from the Taking Diabetes to Heart survey. The global survey

investigated cardiovascular disease (CVD) awareness among 12,695 people with

type 2 diabetes and revealed that 2 in 3 had CVD risk factors such as high

blood pressure, uncontrolled blood glucose levels and high cholesterol and/or

had experienced a CVD event such as angina, heart attack, stroke or heart

failure. 'However, 1 in 4 respondents had never discussed, or cannot remember

discussing, CVD risk factors with a doctor and only 1 in 4 considered

themselves to be at low risk of CVD.'[2]

    Commenting on the findings, IDF President Professor Nam H. Cho said: "These

survey findings confirm our concerns about the increasing global prevalence of

diabetes and its associated complications. Awareness of the risks and

consequences of the disease remains pitifully low and education to address

diabetes complications is lacking. We urge governments to invest in measures to

detect type 2 diabetes early and ensure that health professionals are trained

to guide people to make positive changes to their lifestyle and better manage

their diabetes. This will help people to avoid disabling and life-threating

diabetes complications."

    Diabetes currently affects 425 million adults worldwide,[3] with most cases

being type 2 diabetes. CVD, which includes stroke, coronary heart disease and

peripheral artery disease,[4] is the leading cause of disability and death in

people with type 2 diabetes.[1]

    In the Taking Diabetes to Heart survey, 3 in 4 people with type 2 diabetes

said they relied on information about CVD from their doctor. More than half of

respondents said they needed more information about the risk factors associated

with the development of CVD to better understand the risks in order to help

prevent them.[2]

    "Cardiovascular disease can have a devastating impact on the lives of

people with type 2 diabetes and their families," said Professor Stephen Gough,

global chief medical officer of Novo Nordisk. "The IDF survey findings are

striking and reinforce the importance of raising awareness of CVD risk and its

impact on people living with type 2 diabetes. We are committed to continue

working with IDF while utilising these global findings to inform future efforts

that can help improve health outcomes."

    Taking Diabetes to Heart will culminate in a comprehensive report with

regional and country-specific results and resources to help support knowledge

and awareness of CVD among people with type 2 diabetes and those at risk around

the world.

    For more information about Taking Diabetes to Heart, visit

www.idf.org/takingdiabetes2heart [http://www.idf.org/takingdiabetes2heart ]

    For more information about diabetes and cardiovascular disease, visit

www.idf.org/cvd [http://www.idf.org/cvd ]

    About Taking Diabetes to Heart

    Taking Diabetes to Heart - www.idf.org/takingdiabetes2heart

[http://www.idf.org/takingdiabetes2heart ] - is the first ever multi-country,

online survey investigating the level of cardiovascular disease awareness and

knowledge among people with type 2 diabetes. Respondents from over 130

countries participated around the world, with more than 12,000 responses

received. The survey is now closed. Results from the survey will be used to

inform policy and decision-making around this common and serious complication

of diabetes.[3]

    About the International Diabetes Federation

    The International Diabetes Federation (IDF) is an umbrella organisation of

over 240 national diabetes associations in 168 countries and territories. It

represents the interests of the growing number of people with diabetes and

those at risk. The Federation has been leading the global diabetes community

since 1950. The Federation's activities aim to influence policy, increase

public awareness and encourage health improvement, promote the exchange of

high-quality information about diabetes, and provide education for people with

diabetes and their healthcare providers. www.idf.org [http://www.idf.org ].

    About Novo Nordisk

    Novo Nordisk is a global healthcare company with 95 years of innovation and

leadership in diabetes care. This heritage has given us experience and

capabilities that also enable us to help people defeat obesity, haemophilia,

growth disorders and other serious chronic diseases. Headquartered in Denmark,

Novo Nordisk employs approximately 43,100 people in 79 countries and markets

its products in more than 170 countries. For more information, visit

novonordisk.com [https://www.novonordisk.com ], Facebook

[https://www.facebook.com/novonordisk ], Twitter

[https://twitter.com/novonordisk ], LinkedIn

[http://www.linkedin.com/company/novo-nordisk ], YouTube

[http://www.youtube.com/novonordisk ].

    Further information

    Media: Katrine Sperling, +45-4442-6718, krsp@novonordisk.com

    Investors: Peter Hugreffe Ankersen, +45-3075-9085, phak@novonordisk.com

Anders Mikkelsen, +45-3079-4461, armk@novonordisk.com Valdemar Borum Svarrer,

+45-3079-0301, jvls@novonordisk.com

    References

    1) Low Wang CC, Hess CN, Hiatt WR, et al. Clinical Update: Cardiovascular

Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart

Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical

Considerations. Circulation. 2016;133:2459-2502.

    2) International Diabetes Federation. Taking Diabetes to Heart Survey

Results. Available at

https://www.idf.org/our-activities/care-prevention/cardiovascular-disease/taking-diabetes-to-heart].

Last accessed: September 2018.

    3) International Diabetes Federation. IDF Diabetes Atlas. 8th edition.

Brussels, Belgium. 2017. Available at: http://www.diabetesatlas.org. Last

accessed: September 2018.

    4) International Diabetes Federation. Diabetes and Cardiovascular Disease.

2016. Available at: www.idf.org/cvd [http://www.idf.org/cvd ]. Last accessed:

September 2018.

SOURCE: Novo Nordisk